Medical Director, Safety Strategy & Risk Management

Gsk; England; Híbrido; GBP 90.000 - 150.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Hybrid work arrangement

On-site 2–3 days/week

Descripción de la vacante

GSK is seeking an Associate Medical Director, Safety Evaluation and Risk Management (SERM) to provide medical leadership in safety evaluation and risk management for assets in development and post‑marketing. You will collaborate with Clinical Operations, Safety, Regulatory, Biostatistics, and Commercial to drive evidence‑based safety decisions.

You will ensure rigorous review of data, escalation of safety issues, and communication of safety risks to senior management and governance committees,

Formación

• Medical degree with postgraduate clinical training or residency.
• Experience in pharmacovigilance or drug safety in pharma/biotech.
• Experience with safety strategy development and international pharmacovigilance requirements.

Responsabilidades

• Provide medical leadership across safety evaluation and risk management for assets in development and post-marketing.
• Lead cross-functional safety governance and ensure risk-reduction strategies in protocols and labeling.
• Contribute to safety governance processes, CMC and regulatory submissions, and safety communications.
• Prepare detailed safety evaluations and reports for major products and interact with senior governance committees.

Conocimientos

Medical degree

Pharmacovigilance experience

Clinical safety expertise

Regulatory submissions knowledge

Communication skills

Educación

Postgraduate clinical training

Residency

Descripción del empleo

GSK is seeking an Associate Medical Director, Safety Evaluation and Risk Management (SERM) to provide medical leadership in safety evaluation and risk management for assets in development and post‑marketing. You will collaborate with Clinical Operations, Safety, Regulatory, Biostatistics, and Commercial to drive evidence‑based safety decisions.

You will ensure rigorous review of data, escalation of safety issues, and communication of safety risks to senior management and governance committees,